Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a Tertiary Care Hospital of Papeete, French Polynesia

被引：93

作者：

Naas, T ^{[1
]}

Levy, M

Hirschauer, C

Marchandin, H

Nordmann, P

机构：

[1] Univ Paris 11, Serv Bacteriol Virol, AP HP, Hop Bicetre,Fac Med Paris Sud, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France

[2] Ctr Hosp Polynesie Francaise, Biol Lab, Papeete, Tahiti, France

[3] CHU Montpellier, Serv Bacteriol Virol, Montpellier, France

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2005年 / 43卷 / 09期

关键词：

D O I：

10.1128/JCM.43.9.4826-4829.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 24 patients between March and May 2004 at the Centre Hospitalier de Polynesie Francaise, Tahiti, French Polynesia. The isolates were multidrug resistant, produced the carbapenemase OXA-23, and belonged to a single clone presenting several subtypes, suggesting an endemic situation. This study further illustrates the global spread of this kind of beta-lactamase-mediated resistance.

引用

收藏

页码：4826 / 4829

页数：4

相关论文

共 20 条

[1] Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina [J].

Afzal-Shah, M ;

Villar, HE ;

Livermore, DM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :127-131

[2] Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].

Afzal-Shah, M ;

Woodford, N ;

Livermore, DM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588

[3]

[Anonymous], [No title captured]

[4] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].

BergogneBerezin, E ;

Towner, KJ .

CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+

[5] OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J].

Bou, G ;

Oliver, A ;

Martínez-Beltran, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1556-1561

[6] Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases [J].

Bou, G ;

Cerveró, G ;

Domínguez, MA ;

Quereda, C ;

Martínez-Beltrán, J .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3299-3305

[7]

*COM TECHN NAT INF, 1999, 100 REC SURV PREV IN

[8] Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil [J].

Dalla-Costa, LM ;

Coelho, JM ;

Souza, HAPHM ;

Castro, MES ;

Stier, CJN ;

Bragagnolo, KL ;

Rea-Neto, A ;

Penteado, SR ;

Livermore, DM ;

Woodford, N .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) :3403-3406

[9] Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92 [J].

Donald, HM ;

Scaife, W ;

Amyes, SGB ;

Young, HK .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :196-199

[10] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].

GARNER, JS ;

JARVIS, WR ;

EMORI, TG ;

HORAN, TC ;

HUGHES, JM .

AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140